跳至主要内容
临床试验/ISRCTN07027313
ISRCTN07027313已完成不适用

Randomised double blind trial to evaluate prevention of breast cancer using tamoxifen in high risk wome

Royal Marsden Hospital (UK)0 个研究点目标入组 2,500 人开始时间: 2007年1月26日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
2,500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. Healthy women
  • 2. Aged 30 to 70 years
  • 3. Life expectancy of more than ten years
  • 4. Psychologically and physically suitable for tamoxifen/placebo and long term follow-up
  • 5. At increased risk of breast cancer by virtue of:
  • a. at least one first degree relative aged under 50 with breast cancer
  • b. one first degree relative with bilateral breast cancer
  • c. one first degree relative of any age plus another affected first or second degree relative
  • d. history of a high risk benign breast biopsy

排除标准

  • 1. Clinical or screening evidence of breast cancer
  • 2. Pregnant or lactating women
  • 3. Pregnancy risk - unless a disclaimer was signed
  • 4. Oral contraceptives within the previous three months
  • 5. Previous history of non-invasive or invasive breast cancer
  • 6. Previous history of other malignancy (except Basal Cell Carcinoma [BCC] or Carcinoma [CA] in situ of the cervix)
  • 7. History of deep vein thrombosis or pulmonary embolism

研究者

发起方
Royal Marsden Hospital (UK)

相似试验